Michael Clay MRC Centre for Inflammation Research, The Queen's Medical Research Institute The University of Edinburgh Biography Publications Institution JoVE Articles Michael Clay has not added a biography. If you are Michael Clay and would like to personalize this page please email our Author Liaison for assistance. Publications Epidemiology of Concussion in Sport: a Literature Review Journal of Chiropractic Medicine. Dec, 2013 | Pubmed ID: 24396326 MAST2 and NOTCH1 Translocations in Breast Carcinoma and Associated Pre-invasive Lesions Human Pathology. Dec, 2013 | Pubmed ID: 24140425 Teaching While Learning While Practicing: Reframing Faculty Development for the Patient-centered Medical Home Academic Medicine : Journal of the Association of American Medical Colleges. Sep, 2013 | Pubmed ID: 23887006 Clinicopathologic Characteristics of HER2 FISH-ambiguous Breast Cancer at a Single Institution The American Journal of Surgical Pathology. Jan, 2013 | Pubmed ID: 23108020 Conditional Ablation of Macrophages Disrupts Ovarian Vasculature Reproduction (Cambridge, England). Jun, 2011 | Pubmed ID: 21393340 Microscopic Uterine Lymphangioleiomyomatosis Perivascular Epithelioid Cell Neoplasm: a Case Report with the Earliest Manifestation of This Enigmatic Neoplasm International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. Jan, 2011 | Pubmed ID: 21131829 No Evidence of Human Clonally Transmissible Anogenital Cancer International Journal of Surgical Pathology. Aug, 2010 | Pubmed ID: 20627958 Peroxo-type Intermediates in Class I Ribonucleotide Reductase and Related Binuclear Non-heme Iron Enzymes Journal of the American Chemical Society. Sep, 2009 | Pubmed ID: 19663382 Catalytic Effectiveness, a Measure of Enzyme Proficiency for Industrial Applications Trends in Biotechnology. Mar, 2009 | Pubmed ID: 19193465 Spectroscopic and Electronic Structure Studies of Intermediate X in Ribonucleotide Reductase R2 and Two Variants: a Description of the FeIV-oxo Bond in the FeIII-O-FeIV Dimer Journal of the American Chemical Society. Jul, 2007 | Pubmed ID: 17602477 Azetidinones As Vasopressin V1a Antagonists Bioorganic & Medicinal Chemistry. Mar, 2007 | Pubmed ID: 17234419 Comparing the Electronic Properties of the Low-spin Cyano-ferric [Fe(N4)(Cys)] Active Sites of Superoxide Reductase and P450cam Using ENDOR Spectroscopy and DFT Calculations Journal of the American Chemical Society. Dec, 2006 | Pubmed ID: 17177406 Local Amplification of Glucocorticoids by 11 Beta-hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes Journal of Immunology (Baltimore, Md. : 1950). Jun, 2006 | Pubmed ID: 16751407 Spectroscopy and Electronic Structures of Mono- and Binuclear High-valent Non-heme Iron-oxo Systems Journal of Inorganic Biochemistry. Apr, 2006 | Pubmed ID: 16510189 Geometries and Electronic Structures of Cyanide Adducts of the Non-heme Iron Active Site of Superoxide Reductases: Vibrational and ENDOR Studies Biochemistry. Jan, 2006 | Pubmed ID: 16401073 Dipeptides As Effective Prodrugs of the Unnatural Amino Acid (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740), a Selective Group II Metabotropic Glutamate Receptor Agonist Journal of Medicinal Chemistry. Aug, 2005 | Pubmed ID: 16078848 LY503430: Pharmacology, Pharmacokinetics, and Effects in Rodent Models of Parkinson's Disease CNS Drug Reviews. 2005 | Pubmed ID: 15867954 Persistence of Apoptotic Cells Without Autoimmune Disease or Inflammation in CD14-/- Mice The Journal of Cell Biology. Dec, 2004 | Pubmed ID: 15611337 Synthesis and Biological Evaluation of an Orally Active Ghrelin Agonist That Stimulates Food Consumption and Adiposity in Rats Bioorganic & Medicinal Chemistry Letters. Dec, 2004 | Pubmed ID: 15501059 Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones As Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3 Journal of Medicinal Chemistry. Jul, 2004 | Pubmed ID: 15267232 Spectroscopic Investigation of the Nickel-containing Porphinoid Cofactor F(430). Comparison of the Free Cofactor in the (+)1, (+)2 and (+)3 Oxidation States with the Cofactor Bound to Methyl-coenzyme M Reductase in the Silent, Red and Ox Forms Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry. Jul, 2004 | Pubmed ID: 15160314 Synthesis and Structure-activity Relationships of Novel Arylpiperazines As Potent and Selective Agonists of the Melanocortin Subtype-4 Receptor Journal of Medicinal Chemistry. Jan, 2004 | Pubmed ID: 14736255 Spectroscopic Characterization of the [Fe(His)(4)(Cys)] Site in 2Fe-superoxide Reductase from Desulfovibrio Vulgaris Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry. Jul, 2003 | Pubmed ID: 12764688 Nitric Oxide Binding at the Mononuclear Active Site of Reduced Pyrococcus Furiosus Superoxide Reductase Proceedings of the National Academy of Sciences of the United States of America. Apr, 2003 | Pubmed ID: 12655067 Resonance Raman Characterization of the Mononuclear Iron Active-site Vibrations and Putative Electron Transport Pathways in Pyrococcus Furiosus Superoxide Reductase Biochemistry. Aug, 2002 | Pubmed ID: 12146949 Superoxide Reductase: Fact or Fiction? Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry. Jun, 2002 | Pubmed ID: 12072972 A Hyperthermophilic Plant-type [2Fe-2S] Ferredoxin from Aquifex Aeolicus is Stabilized by a Disulfide Bond Biochemistry. Mar, 2002 | Pubmed ID: 11863449 Heterodisulfide Reductase from Methanothermobacter Marburgensis Contains an Active-site [4Fe-4S] Cluster That is Directly Involved in Mediating Heterodisulfide Reduction FEBS Letters. Feb, 2002 | Pubmed ID: 11852093 Spectroscopic Studies of Pyrococcus Furiosus Superoxide Reductase: Implications for Active-site Structures and the Catalytic Mechanism Journal of the American Chemical Society. Feb, 2002 | Pubmed ID: 11817955 Mus nyretransplanterte: Modeller av allograft-avstøting George H. Tse*1, Emily E. Hesketh*1, Michael Clay1, Gary Borthwick1, Jeremy Hughes1, Lorna P. Marson1 1MRC Centre for Inflammation Research, The Queen's Medical Research Institute, The University of Edinburgh Médecine Nedsatt Ischemi reperfusjonssykdommer: A Mouse Model of Injury and Regeneration Emily E. Hesketh1, Alicja Czopek1, Michael Clay1, Gary Borthwick1, David Ferenbach1, David Kluth1, Jeremy Hughes1 1MRC Centre for Inflammation Research, University of Edinburgh Médecine
Mus nyretransplanterte: Modeller av allograft-avstøting George H. Tse*1, Emily E. Hesketh*1, Michael Clay1, Gary Borthwick1, Jeremy Hughes1, Lorna P. Marson1 1MRC Centre for Inflammation Research, The Queen's Medical Research Institute, The University of Edinburgh Médecine
Nedsatt Ischemi reperfusjonssykdommer: A Mouse Model of Injury and Regeneration Emily E. Hesketh1, Alicja Czopek1, Michael Clay1, Gary Borthwick1, David Ferenbach1, David Kluth1, Jeremy Hughes1 1MRC Centre for Inflammation Research, University of Edinburgh Médecine